Business Development & Licensing Solutions
Solutions by your business interests
Companies and management
Detailed company directory incl. management contact details
Assets & licensing opportunities
Therapeutics, diagnostics and medical devices available for out-licensing
Benchmark license agreements
Over 33,000 license agreements with financials and many original contracts
Clinical trials
Over 840,000 clinical studies aggregated from 20 global trial registries
Companies and management contacts
One of the core elements of Biotechgate is the detailed company directory containing key information from more than 70,000 companies in sectors such as biotechnology, pharmaceuticals and medical technology.
Identify your next business or collaboration partner with our easy-to-use search tools.
• Notable emerging start-ups and emerging companies
• Over 350,000 management contact details (with many emails and LinkedIn)
• Financial information for over 3,000 publicly traded life science companies
• Unique data set thanks to collaboration with over 30 cluster organizations
• Show results on a map to plan your next road trip
Key features
Excel download for all sections
Visualize results on a map
Save your preferred searches and set -up email alerts
Unique data sourcing process incl. self-declared data and AI
API for direct data access
See who invested in which company
Assets & out-licensing
The asset section is the ideal place to identify emerging companies by their disruptive innovations. You can filter the 96,000+ asset database and see if they are partnered or available for licensing.
Numerous search filters make it easy to find the relevant targets. The asset section is divided into the following areas:
• Therapeutics
• Molecular diagnostics
• Medical devices
• Technology platforms
All results can be visualized on a map to see their geographical distribution around the globe.
Filter for partnered and unpartnered assets
Search for indications and development phase
Excel download and bookmarking
Visualize results on a map
Email alerts for new assets or phase changes
Orphan drugs and 505(b)(2) approval
Benchmark license agreements
A good understanding of industry practices and an in-depth knowledge of how previous contracts were designed is essential to successfully negotiate a deal or understand what contracts your potential partner has already signed.
Biotechgate’s license agreement section contains details from more than 32,000 licensing contracts for Biotech, Pharma and Medtech companies. The data is structured and searchable which allows you to benchmark your upcoming negotiations with existing agreements.
Typical information provided in our database includes:
• Licensor, licensee and compound name
• Press release or a copy of the original licensing deal contract (downloadable pdf)
• Clinical phase and therapeutic area / indication
• Collaboration type and territory
• Financials, such as upfront and milestone payments, total deal size and royalties
See Sample License Agreements
Click on a link below to download some of our over 32,000 license agreements free of charge:
• Sangamo Therapeutics, Inc. – Novartis International AG (2020)
• Nektar Therapeutics Inc – Bristol-Myers Squibb (2018)
• Vericel Corporation – Innovative Cellular Therapeutics (2017)
Upfront, milestone payments and royalties
Including original source of license agreement
Powerful tools to analyze and filter agreements
Global clinical trial directory
Biotechgate provides a clinical trial database with over 820,000 clinical studies, aggregated from 20 trial registries from around the world. Wherever feasible, the trial studies are linked to one of over 60,000 company profiles in Biotechgate. This allows navigating from the clinical trials to the corresponding company information, its technologies, financing, licensing or management.
Alter Feature
Biotechgate’s clinical trial directory is used by business development professionals from around the globe to identify early-stage companies and products. Besides comprehensive search filters, with the Biotechgate alert feature, you can set up automated email alerts to be notified when new trials are added or studies of interest are updated.
Recruitment status
Search by sponsor
Clinical phase
Clinical status of study *
Disease, indication and type of intervention
Filter by date of registration, enrollment and latest update
Source register (20 registries from all continents)
* an indicator estimated by Biotechgate based on registration date, trial activity updates and clinical phase